Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

Clinical trial NCT01352663 · WITHDRAWN

Trial details

NCT number: NCT01352663
Sponsor: Wockhardt
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Type I Diabetes

Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.